South Texas Accelerated Research Therapeutics is Laboratory Services (Healthcare) in United States that focus on clinical research business. Founded in 2007. They cover business area such as provider, clinical trial, clinical research, a cure, deadly disease, I, new anticancer drug, life, survival, patient.
Laboratory Services (Healthcare)
2007
( 17 years old in 2024 )
Clinical Research
-
4383 Medical Drive
San Antonio, TX 78229
United States
Private
providerclinical trialclinical researcha curedeadly diseaseInew anticancer druglifesurvivalpatient
* We use standard office opening hours in near South Texas Accelerated Research Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
South Texas Accelerated Research Therapeutics is Laboratory Services (Healthcare) business from United States that founded in 2007 (17 years old in 2024), South Texas Accelerated Research Therapeutics business is focusing on Clinical Research.
South Texas Accelerated Research Therapeutics headquarter office and corporate office address is located in 4383 Medical Drive San Antonio, TX 78229 United States.
South Texas Accelerated Research Therapeutics was founded in United States.
In 2024, South Texas Accelerated Research Therapeutics is currently focus on clinical research sector.
Above is snippet of Google Trends for "clinical research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with South Texas Accelerated Research Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
